Printer Friendly

Browse Harachand, S.

1-85 out of 85 article(s)
Title Type Date Words
India to Track API Packs: India is mulling a shakeup in the regulations governing the distribution of pharmaceutical products, even as the packaging industry readies for a big leap forward. Nov 1, 2019 717
Indian Firms Ramp Up R&D: Accelerating on research spend. Oct 1, 2019 705
Highly Potent Expansions: CDMOs see HPAPI demand rising. Sep 1, 2019 795
The Orphan Promise: New policy on rare disease treatments likely soon. Jun 1, 2019 834
Ebullient Bio CMOs: Firms see rich dividends from biosimilars. May 1, 2019 764
India Eases Price Control On Novel Drugs: No price cap for innovator products for 5 years. Mar 1, 2019 785
Strategic Discovery: CROs top offerings with biology skills. Oct 1, 2018 739
HPAPI Outsourcing Likely to Gain Traction: A number of highly potent drugs will soon fall into the generic domain. Sep 1, 2018 723
India raises bar for clinical trial oversight: New guidelines to bolster institutional ethical committees. May 1, 2018 742
CMOs Growing Strong in APIs: Major API players in India continue to invest in operations. Apr 1, 2018 756
Packaging Majors Expand Base in India: India's pharma packaging market is growing at a faster pace than other world markets. Mar 1, 2018 764
Acquisition Spree: Indian firms topped the list of aggressive bidders even as the frenzy of deal making in the global generics space passes into yet another year. Jan 1, 2018 764
India is an Emerging Hub For Low-cost Vaccines: Improvising basic vaccines to enhance stability, efficacy and compliance. Nov 1, 2017 772
Growing NDDS Portfolios: Generic drugs on novel delivery platforms. Oct 1, 2017 747
Marketing code round the corner: proposal to limit giveaways; offenders face product ban. Sep 1, 2017 809
India frames guidance for drug surveillance: outsourcing PV functions to rise. Jul 1, 2017 705
Indian generic firms expand biosimilar portfolios: with more players entering the ring, the race to enter the promising biosimilars market is getting hotter by the day in India. May 1, 2017 707
WHO lauds India's vaccine safety. Apr 1, 2017 802
Booster dose for device makers: new device rules effective from January 2018. Mar 1, 2017 756
API makers speed expansion: CMOs chart course through M&A route. Jan 1, 2017 745
India on GMP drive: only work force with certified skills can run factories. Nov 1, 2016 762
CROs get policy booster: firms can run more trials; site norms eased up. Oct 1, 2016 810
FDI green light sets the stage: M&A activity and outsourcing to gather pace. Sep 1, 2016 720
Discovery: the new Mantra: R&D spend shoots up as firms turn research savvy. Jul 1, 2016 785
Betting big on injectables: firms hone skills and boost capacities. Jun 1, 2016 778
India revises biosimilars guidelines: stricter quality, safety norms on cards. May 1, 2016 737
Data integrity riddle: firms join hands to resolve quality issues. Apr 1, 2016 817
Seeking Zika vac: race for India's vac space heats up. Mar 1, 2016 797
Great expectations: new drugs & devices ministry to hasten approvals. Jan 1, 2016 741
Going the GMP way: CMOs see surge in demand. Nov 1, 2015 763
A policy device: making India a low-cost devices hub. Oct 1, 2015 708
CROs are making headlines: India's drug discovery service sector is heating up. Sep 1, 2015 786
APIs: looking for an Indian angle: generic majors zoom in as CMOs boost capacities. Jul 1, 2015 766
Emerging hotbed of surveillance data? Offshoring moves to Indian shores as regulations evolve. Jun 1, 2015 725
Total compliance: regulators take the lead: states hire services to train officers to be audit-ready. May 1, 2015 742
Sought-after vaccine partners: Vacs makers turn hot targets for M&As. Apr 1, 2015 796
Regulator opens pre-filing window: helping CROs know where they stand. Mar 1, 2015 742
India reviews patent policy: can it snip contested clauses? Jan 1, 2015 792
Cost of compliance: India raises the bar in production quality. Nov 1, 2014 773
India's one-stop shops: outsourcing industry takes a big leap forward; vendors transform to partners over the years. Oct 1, 2014 716
India will fast-track clinical trial approvals: the government plans to improve response times, win back trust and restore growth momentum. Sep 1, 2014 744
Indian generics expand in mAbs: as they focus on generic biologies, Indian firms are setting their sights on monoclonal antibodies. Jul 1, 2014 733
India tightens clinical trial requirements: the government is scrutinizing the way that severe adverse effects are reported, and revisiting financial compensation requirements. Jun 1, 2014 767
Granules India bets on its PFI formula: bridging the gap between formulation and tablet manufacturing, pharmaceutical formulation intermediate (PFI) outsourcing promises sponsors time and cost reduction. Apr 1, 2014 676
Consent on camera: grappling with a hazy order. Jan 1, 2014 774
Unlocking the value of injectables: injectables CMOs steal the show. Company overview Nov 1, 2013 821
Accredited trials: will CROs need accreditation for approval? Oct 1, 2013 812
Getting used to user fees: after GDUFA, will CMOs rethink their strategies? Sep 1, 2013 806
Acting on APIs: tightening norms for exports, imports. Jul 1, 2013 792
Safe trials: safety stymies free-play? Jun 1, 2013 801
3 (d) the third dimension: limit the verdict to Glivec. May 1, 2013 807
Active & non-active deals: APIs behind big buys. Apr 1, 2013 800
(Bio)similar deals: new models emerge in biogenerics sourcing. Jul 1, 2012 845
CROs turn proactive: online tool to clean up errants. Jun 1, 2012 817
Discovering discovery? CMOs get spirited on discovery models. May 1, 2012 833
Move to monoclonals: CMOs' MAb skills in the spotlight. Apr 1, 2012 782
On the API trail: expansions, exits and much more. Mar 1, 2012 812
A clinical act: a regulator emerges as savior. Jan 1, 2012 847
CEOs make the sojourn: multinationals get bullish about India. Nov 1, 2011 798
A decisive market for device makers: tie-ups can cut costs. Oct 1, 2011 799
Drug safety--a safe bet: sudden spurt in pharmacovigilance activity. Sep 1, 2011 804
CRAMS rising: quality will benchmark growth. Jul 1, 2011 841
Biotech rebounds: generics, vaccines fuel growth. Jun 1, 2011 758
Eyeing a 'similar' pie: is a bet on cheaper bio-drugs safe? May 1, 2011 815
Niche play: specialized API makers buck the trend. Apr 1, 2011 791
Getting India-centric? In-and-out deals fire up market through 2011. Mar 1, 2011 772
Testing the trials: regular audits of trial sites are in force. Jan 1, 2011 796
Eyes on the OTC prize: MNCs turn antennae to Paras. Nov 1, 2010 818
Advinus speeds through discovery maze: Q&A with Dr. Rashmi H. Barbhaiya. Interview Oct 1, 2010 828
Nutraceuticals: ready for take off? A growing niche in India's market. Sep 1, 2010 791
Springboard for up & coming markets: Indian CMOs become indispensable? Jul 1, 2010 813
Vaccine players on the move: great potential for vaccine services. Jun 1, 2010 847
High on high-potency: CMOs on the look-out for HPAPI skills. May 1, 2010 817
Patents without exclusivity: IP rights granted, but not protected. Apr 1, 2010 836
CROs move to India's hinterlands: tier 2 and 3 cities benefit. Mar 1, 2010 850
Generics: the great game-changer: equation-changing deals blaze up the CMO stage. Jan 1, 2010 804
Still hunting soft skills: skill-crunch threatens the CRO boom. Clinical report Nov 1, 2009 819
The emerging second wave: high-quality, low-cost bio-CMOs rally forth. Oct 1, 2009 826
Strategic boost for CMOs: India's CMO business grows at 3X the global rate. Sep 1, 2009 705
Booming devices in search of a regulator: devices outsourcing expects a booster from speeding growth. Jul 1, 2009 831
India bolsters trial ethics code: stricter laws are in the cards, and concerns remain. Jun 1, 2009 851
Who follows the follow-Ons? Generics makers are charting a course for biosimilars. May 1, 2009 846
Eyeing the niche: injectables make manufacturers chant the niche mantra. Apr 1, 2009 834
Solids get stronger: CMOs see on-patent oral solid dosage drugs in their baskets. Mar 1, 2009 853
A dream run during a downturn: API makers see exports triple in three years. Jan 1, 2009 817

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |